Lexicon Pharmaceuticals
LXRX
#6851
Rank
โ‚ฌ0.66 B
Marketcap
1,50ย โ‚ฌ
Share price
-4.55%
Change (1 day)
16.74%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚ฌ52.85 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ41.46 Million. In 2025 the company made an earning of -โ‚ฌ44.93 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ52.85 Million17.62%
2025 -โ‚ฌ44.93 Million-74.88%
2024 -โ‚ฌ0.18 Billion13.15%
2023 -โ‚ฌ0.16 Billion73.74%
2022 -โ‚ฌ90.98 Million16.16%
2021 -โ‚ฌ78.32 Million49.82%
2020 -โ‚ฌ52.28 Million-147.19%
2019 โ‚ฌ0.11 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ4.18 Million-95.33%
2014 -โ‚ฌ89.57 Million-3.61%
2013 -โ‚ฌ92.93 Million-5.52%
2012 -โ‚ฌ98.36 Million-4.17%
2011 -โ‚ฌ0.11 Billion15.5%
2010 -โ‚ฌ88.87 Million8.36%
2009 -โ‚ฌ82.01 Million-4.81%
2008 -โ‚ฌ86.15 Million28.79%
2007 -โ‚ฌ66.89 Million35.71%
2006 -โ‚ฌ49.29 Million52.91%
2005 -โ‚ฌ32.24 Million-23.89%
2004 -โ‚ฌ42.35 Million-24.19%
2003 -โ‚ฌ55.86 Million-0.48%
2002 -โ‚ฌ56.13 Million44.12%
2001 -โ‚ฌ38.95 Million23.01%
2000 -โ‚ฌ31.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ6.81 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.03 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.61 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.46 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.21 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ70.84 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.75 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.13 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ14.75 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA